6,029 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Acquired by Allstate Corp

Allstate Corp bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 6,029 shares of the medical device company's stock, valued at approximately $554,000.

Other large investors have also recently modified their holdings of the company. Brown Brothers Harriman & Co. boosted its stake in shares of Cooper Companies by 227.2% in the 4th quarter. Brown Brothers Harriman & Co. now owns 1,371 shares of the medical device company's stock valued at $126,000 after purchasing an additional 952 shares in the last quarter. DnB Asset Management AS lifted its stake in Cooper Companies by 0.8% in the 4th quarter. DnB Asset Management AS now owns 34,332 shares of the medical device company's stock valued at $3,156,000 after purchasing an additional 279 shares during the last quarter. Pictet Asset Management Holding SA boosted its position in Cooper Companies by 7.1% in the fourth quarter. Pictet Asset Management Holding SA now owns 145,085 shares of the medical device company's stock valued at $13,338,000 after buying an additional 9,650 shares in the last quarter. New Age Alpha Advisors LLC bought a new stake in shares of Cooper Companies during the fourth quarter worth $38,000. Finally, Norges Bank bought a new stake in shares of Cooper Companies during the fourth quarter worth $217,906,000. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Trading Down 5.6 %

COO stock traded down $4.40 during midday trading on Friday, hitting $73.77. The stock had a trading volume of 2,661,526 shares, compared to its average volume of 1,367,710. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market cap of $14.75 billion, a P/E ratio of 37.83, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The business has a fifty day moving average price of $87.76 and a two-hundred day moving average price of $96.14. The Cooper Companies, Inc. has a 1-year low of $73.34 and a 1-year high of $112.38.

Remove Ads

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. On average, sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on COO shares. Citigroup cut their price objective on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Finally, Robert W. Baird decreased their price target on shares of Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $110.25.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.